PeerView Oncology & Hematology CME/CNE/CPE Audio Podcast
- Education
- Health & Fitness · Medicine
- Science
Free on the App Store for iPhone, iPad and Mac. No subscription. Once it is installed, tap this link again and the show is yours. Already have it? Open in Parasocial.
About
PeerView (PVI) is a leading provider of high-quality, innovative continuing education (CME/CE/CPE and MOC) for clinicians and their interprofessional teams. Combining evidence-based medicine and instructional expertise, PeerView activities improve the knowledge, skills, and strategies that support clinical performance and patient outcomes. PeerView makes its educational programming and expert-led presentations and symposia available through its network of popular podcast channels to support specific specialties and conditions. Each episode includes a link to request CME/CE credit for participation. PeerView is solely responsible for the selection of topics, the preparation of editorial content, and the distribution of all materials it...
Also on
Recent episodes
- Barrett Craig Lawson, MD, Joyce Liu, MD, MPH - Powering Pathology Precision: Expert Strategies for Folate Receptor Alpha Testing to Guide Personalized ADC Care in Advanced Ovarian Cancer
- Nicholas M. Bernthal, MD, FAOA / Prof. Hans Gelderblom, MD - The ABCs of TGCT: Accurate Diagnosis, Understanding Patient Burden, and Coordinating Collaborative Multidisciplinary Care
- Alicia K. Morgans, MD, MPH, FASCO, Matthew B. Rettig, MD - The March of Innovation in Prostate Cancer: Advancing Veteran Care With an Expanding and Personalized Treatment Arsenal
- Brian Slomovitz, MD, MS, FACOG - Next-Generation Strategies in Advanced Ovarian Cancer: Are You Prepared to Harness Novel Mechanisms of Action and the Latest Therapeutic Innovations?
- Neal D. Shore, MD, FACS - Directing Better Outcomes in Prostate Cancer: Urologist Leadership in Personalizing Treatment Innovation and Delivering Patient-Centered Care
- Michael R. Grunwald, MD, FACP - The A-Factor in Myelofibrosis: Addressing Anemia and Prioritizing Personalized Team Management
- Dr. Paula Cramer - Mapping the Pathways to Long-Term Treatment Benefit in Chronic Lymphocytic Leukemia (CLL): Strategies for Aligning Patient Priorities With Evidence for Initiating and Sequencing Targeted Therapy
- Associate Professor Jim Whittle, MBBS, PhD, FRACP / Katie Metrock, MD - Moving MEK Inhibitor Therapy FORWARD in NF1: A Neuro-Oncology FOrum on Real-World Application of Recent Data for Improving Patient Care
- Dr. Toby A. Eyre, MBChB, DipMedEd, MRCP, FRCPath, MD - Rethinking the CLL Treatment Sequence: Guidance on Selecting and Sequencing Modern Treatment for Sustained Efficacy Across Lines of Therapy
- Jonathan W. Goldman, MD - Evolving Strategies in Testing and Treatment of MET-Altered NSCLC: Clinical Complexities and Real-World Practicalities